given the shares on issue COLINK60 unlikely
have to be realistic in the forecasts and estimations
if you have a look at the wise owl research report though, they do show the potential to get up to 30 - 40c based on sales and it shows the required volumes etc
then again, the burette market is quite substantial $3Bn+ p.a, so anything can happen. all comes down to how much of the pie ALT can secure
alto - top bio/pharma leverage play, page-6
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)